Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ACLY | P53396 | 3/20 | 0.37 |
| ▸ | SLC13A5 | Q86YT5 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | PAM | P19021 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16241770 | 0.96 | ALDH1A1 (0.54) | ALDH1A1ACLYSLC13A5LMNAKDM4E | |
| SCHEMBL2761470 | 0.96 | ALDH1A1 (0.58) | ALDH1A1ACLYSLC13A5LMNAKDM4E | |
| SCHEMBL28538390 | 0.95 | ALDH1A1 (0.52) | ALDH1A1ACLYLMNAMEN1KMT2A | |
| SCHEMBL11061145 | 0.95 | ALDH1A1 (0.52) | ALDH1A1ACLYLMNAMEN1KMT2A | |
| SCHEMBL10388862 | 0.93 | ALDH1A1 (0.54) | ALDH1A1ACLYSLC13A5LMNAKDM4E | |
| SCHEMBL119742 | 0.92 | ALDH1A1 (0.62) | ALDH1A1ACLYSLC13A5LMNAKDM4E | |
| SCHEMBL11115362 | 0.92 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2ATSHRALOX15 | |
| SCHEMBL27911416 | 0.90 | ALDH1A1 (0.60) | ALDH1A1ACLYSLC13A5LMNAKDM4E | |
| SCHEMBL8514388 | 0.90 | PAM (0.47) | ALDH1A1MEN1KMT2ATSHRALOX15 | |
| SCHEMBL7091543 | 0.90 | PAM (0.47) | ALDH1A1MEN1KMT2ATSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190864-A1 | Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF | YA THERAPEUTICS INC (CN) | 2024-06-13 | — | — | US | disclosed |
| US-20240109896-A1 | FGFR KINASE INHIBITOR AND USE THEREOF | YA THERAPEUTICS INC (CN) | 2024-04-04 | — | — | US | disclosed |
| EP-3510199-A1 | METHOD FOR MANUFACTURE OF PAPER, BOARD OR THE LIKE AND USE OF THE COMPOSITION | Kemira Oyj (FI) | 2019-07-17 | — | — | EP | disclosed |
| WO-2018046794-A1 | METHOD FOR MANUFACTURE OF PAPER, BOARD OR THE LIKE AND USE OF THE COMPOSITION | KEMIRA OYJ (FI) | 2018-03-15 | — | — | WO | disclosed |
| JP-2007068525-A | COMPOSITION FOR SUPPRESSING REACTION INHIBITION OF PQQGDH | TOYOBO CO LTD | 2007-03-22 | — | — | JP | disclosed |
| US-20070037238-A1 | Composition for suppressing PQQGDH reaction inhibition | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1752530-A1 | Composition for suppression PQQGDH reaction inhibition | Toyo Boseki Kabushiki Kaisha (JP) | 2007-02-14 | — | — | EP | disclosed |
| CN-1912134-A | Method and composition for suppressing PQQGDH reaction inhibition | TOYO BOSEKI (JP) | 2007-02-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109896-A1 | FGFR KINASE INHIBITOR AND USE THEREOF | FGFR1, FGFR2, FGFR3 | ALDH1A1 1185/4885ACLY 1829/4885SLC13A5 1582/4885 |
| US-20240190864-A1 | Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF | BTK, SYK, LYN | ALDH1A1 4339/4885ACLY 4124/4885SLC13A5 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.